Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Cancer|October 15, 1996
Aggressive variants of chromophobe renal cell carcinomaA A Renshaw, E P Henske, K R Loughlin, et al.
The Journal of Nutrition|April 1, 1991
Influence of dietary fat, vitamin E, ethoxyquin and indomethacin on the synthesis of prostaglandin E2 in brain regions of miceM Meydani, S N Meydani, A C Shapiro, et al.
The Journal of Clinical Investigation|May 1, 1970
Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxineJ H Oppenheimer, H L Schwartz, H C Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinomaW M Stadler, T Kuzel, C Shapiro, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 29, 2017
Professional Responsibility, Consensus, and Conflict: A Survey of Physician Decisions for the Chronically Critically Ill in Neonatal and Pediatric Intensive Care UnitsMiriam C Shapiro, Pamela K Donohue, Sapna R Kudchadkar, et al.
Blood Cancer Journal|September 15, 2021
Therapeutic targeting of the inflammasome in myeloid malignanciesSamarpana Chakraborty, Lauren C Shapiro, Sofia de Oliveira, et al.
Journal of Clinical Psychopharmacology|February 1, 1997
Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorderB Baker, P Dorian, P Sandor, et al.
Science (New York, N.Y.)|December 16, 1977
Fibrous apatite grown on modified collagenE Banks, S Nakajima, L C Shapiro, et al.
Cancer|November 1, 1981
Disseminated Trichosporon beigelii (cutaneum)C W Yung, S B Hanauer, D Fretzin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2R J Soiffer, C Murray, C Shapiro, et al.
Pageof 16